Xylo Technologies Ltd

Aktienanalyse zu Xylo Technologies Ltd (XYLO)

$5.070

0.000 (0.00%)Zum Schluss

Loading chart…
High
5.119
Open
5.070
VWAP
5.09
Vol
5.15K
Mkt Cap
Low
5.070
Amount
26.18K
EV/EBITDA, TTM
0.00

Xylo Technologies Ltd, formerly known ad Medigus Ltd, is an Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).

medigus.com

Bewertungskennzahlen

The current forward P/E ratio for Xylo Technologies Ltd (XYLO) is 0.84, compared to its 5-year average forward P/E of -6.44.

Forward P/E

Fair
5Y Average P/E
-6.44
Current P/E
0.84
Überbewertet
21.30
Unterbewertet
-34.18

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward P/S

Fair
5Y Average P/S
0.67
Current P/S
0.03
Überbewertet
2.30
Unterbewertet
-0.95

Event-Zeitleiste

2025-12-01 (ET)

08:50:00

SciSparc Acquires 19.99% Stake in Xylo's Patent Portfolio for Innovative Medical Systems

2025-06-05 (ET)

09:25:38

Xylo Technologies says Viewbix shares to begin trading on Nasdaq

2025-04-30 (ET)

09:21:46

Xylo announces Charging Robotics installed system for wireless charging

2025-04-10 (ET)

09:27:26

Xylo Technologies announces Revoltz launches commercial phase of PORTO EV

News

XYLO FAQ — answered by Alphio AI

Xylo Technologies Ltd, formerly known ad Medigus Ltd, is an Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD). It operates in the Healthcare sector (COMPUTER PROCESSING AND DATA PREPARATION AND PROCE industry).

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten